You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
22 July 2024
Biophytis deploys its partnership strategy and signs two contracts with local agents in Asia
11 July 2024
Biophytis obtains IND approval from the FDA to start its phase 2 OBA study in obesity
1 July 2024
Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris
20 June 2024
Biophytis grants Blanver exclusive rights to BIO101 in Latin America in deal valued at up to €108 Million
Biophytis extends its contract with Atlas to secure financing for its business activities
12 June 2024
Biophytis announces the successful industrial transfer of BIO101 (20-hydroxyecdysone) production by its service provider Seqens